Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 4Unknown 3Withdrawn 1Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 43Thoracic 31Lymphoid 5Other solid neoplasm 3Gastrointestinal 3CNS 3Sarcoma 2Tumor-Agnostic 1Gynecologic 1Genitourinary 1

Conditions

Esophageal Squamous Cell Carcinoma 3Esophageal Neoplasms 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 212Irinotecan 145Leucovorin 139Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Drug Therapy 98Bevacizumab 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Vinorelbine × Gastrointestinal × Clear all
NCT02465736 2024-01-16

Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)

Sun Yat-sen University

Phase 3 Unknown
610 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02665702 2016-01-28

Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas

Fudan University

Phase 2 Unknown
76 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02188615 2014-07-11

NACRFMIE

Taizhou Hospital

Phase 2 Unknown
120 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡